Selcuk Ecza Deposu Ticaret venayi ASIST:SELEC +0.34%79 ROC (Joel Greenblatt) % is 49.10% as of Mar. 2026, which is 84% above its 10-year median of 26.66. GuruFocus rates IST:SELEC with a GF Score™ of 79/100 and a GF Value™ of ₺87.69 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 118 Medical Distribution companies, Selcuk Ecza Deposu Ticaret venayi AS ranks better than 57.63% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Selcuk Ecza Deposu Ticaret venayi AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 49.10%.
The historical rank and industry rank for Selcuk Ecza Deposu Ticaret venayi AS's ROC (Joel Greenblatt) % or its related term are showing as below:
IST:SELEC'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 11.33 Med: 26.66 Max: 49.52
Current: 21.75
During the past 13 years, Selcuk Ecza Deposu Ticaret venayi AS's highest ROC (Joel Greenblatt) % was 49.52%. The lowest was 11.33%. And the median was 26.66%.
IST:SELEC's ROC (Joel Greenblatt) % is ranked better than 57.63% of 118
companies
in the Medical Distribution industry
Industry Median: 15.345
vs IST:SELEC: 21.75
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS ROC (Joel Greenblatt) % Chart
IST:SELEC vs MCK, CAH, COR: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selcuk Ecza Deposu Ticaret venayi AS ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's ROC (Joel Greenblatt) % falls into.
Selcuk Ecza Deposu Ticaret venayi AS ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 49.10% mean?
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a ROC (Joel Greenblatt) % of 49.10% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. This is 84% above median its historical median of 26.66. Over the past decade, Selcuk Ecza Deposu Ticaret venayi AS's ROC (Joel Greenblatt) % has ranged from 11.33 to 49.52. According to the industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #50 out of 118 companies in the Medical Distribution industry, placing it in the top 42.4%.
Is Selcuk Ecza Deposu Ticaret venayi AS's ROC (Joel Greenblatt) % too high?
Selcuk Ecza Deposu Ticaret venayi AS's current ROC (Joel Greenblatt) % of 49.10% is 84% above median its 10-year median of 26.66. Over the past 10 years, this metric has ranged from a low of 11.33 to a high of 49.52. The Medical Distribution industry median ROC (Joel Greenblatt) % is 15.35. Selcuk Ecza Deposu Ticaret venayi AS's value of 49.10% is 220% above this industry median. Based on the distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #50 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's ROC (Joel Greenblatt) % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #50 out of 118 companies for ROC (Joel Greenblatt) %. This puts Selcuk Ecza Deposu Ticaret venayi AS in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 15.35. Selcuk Ecza Deposu Ticaret venayi AS's value of 49.10% is 220% above this benchmark. Historically, Selcuk Ecza Deposu Ticaret venayi AS's own ROC (Joel Greenblatt) % has ranged from 11.33 to 49.52 over the past decade. While the company's 10-year median is 26.66 vs. the industry median of 15.35, Selcuk Ecza Deposu Ticaret venayi AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 15.35, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selcuk Ecza Deposu Ticaret venayi AS's current ROC (Joel Greenblatt) % of 49.10% is 220% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 15.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selcuk Ecza Deposu Ticaret venayi AS's current ROC (Joel Greenblatt) % is 49.10%, which is 84% above median its own 10-year median of 26.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺87.69, compared to a current price of ₺207.70 — trading 136.9% above its estimated fair value. The current ROC (Joel Greenblatt) % is 49.10%, which is 84% above median its 10-year median of 26.66 and 220% above the Medical Distribution industry median of 15.35. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current ROC (Joel Greenblatt) % is 49.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued.
The current stock price of ₺207.70 is trading 136.9% above its estimated GF Value™ of ₺87.69.
GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.
Key valuation signals for IST:SELEC:
ROC (Joel Greenblatt) %: 49.10% (84% above median its 10-year median of 26.66)
GF Value™: ₺87.69 vs. price of ₺207.70 (136.9% above fair value)
Industry Position: 220% above the Medical Distribution median (#50 of 118)
No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selcuk Ecza Deposu Ticaret venayi AS Business Description
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
79GF Score
Get the complete analysis for IST:SELEC
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SELEC has been successfully added to your 
